Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T92072 | Target Info | |||
Target Name | Adenosine A1 receptor (ADORA1) | ||||
Synonyms |
Adenosine receptor A1; A(1) adenosine receptor
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | ADORA1 | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Adenosine A2a receptor (ADORA2A) | Successful Target | ||||
UniProt ID | AA2AR_HUMAN | |||||
Gene Name | ADORA2A | |||||
Synonyms |
Adenosine receptor A2a; ADORA2; A2a Adenosine receptor; A(2A) adenosine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | SCH-442416 | Drug Info | Ki = 0.048 nM | Click to Show More | [1] | |
2 | KF-17837 | Drug Info | IC50 = 1 nM | [2] | ||
3 | Rolofylline | Drug Info | Ki = 108 nM | [5] | ||
4 | Rolofylline | Drug Info | Ki = 108 nM | [6] | ||
5 | SLV320 | Drug Info | Ki = 398 nM | [4] | ||
Co-Target Name | Adenosine A2b receptor (ADORA2B) | Successful Target | ||||
UniProt ID | AA2BR_HUMAN | |||||
Gene Name | ADORA2B | |||||
Synonyms |
Adenosine receptor A2b; A2b Adenosine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Tonapofylline | Drug Info | Ki = 90 nM | Click to Show More | [3] | |
2 | Tonapofylline | Drug Info | Ki = 90 nM | [4] | ||
3 | Rolofylline | Drug Info | Ki = 108 nM | [6] | ||
4 | Rolofylline | Drug Info | Ki = 269 nM | [5] | ||
Co-Target Name | Adenosine A3 receptor (ADORA3) | Clinical trial Target | ||||
UniProt ID | AA3R_HUMAN | |||||
Gene Name | ADORA3 | |||||
Synonyms |
Adenosine receptor A3A; Adenosine receptor A3; Adenosine 3 receptor; A3AR; A3 Adenosine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | SLV320 | Drug Info | Ki = 200 nM | Click to Show More | [4] | |
2 | GS 9667 | Drug Info | Ki ~ 1000 nM | [7] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study. J Med Chem. 2014 Jul 24;57(14):6210-25. | ||||
REF 2 | 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic gluc... J Med Chem. 2001 Jan 18;44(2):170-9. | ||||
REF 3 | Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists. J Med Chem. 2006 Nov 30;49(24):7119-31. | ||||
REF 4 | 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists. Bioorg Med Chem. 2010 Mar 15;18(6):2195-2203. | ||||
REF 5 | Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties. Medchemcomm. 2018 May 14;9(6):951-62. | ||||
REF 6 | Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine. J Med Chem. 1997 Jun 6;40(12):1773-8. | ||||
REF 7 | Design and in Vivo Characterization of A 1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series. J Med Chem. 2019 Feb 14;62(3):1502-1522. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.